Health Care [ 3/12 ] | Biotechnology [ 26/74 ]
NASDAQ | Common Stock
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.
The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that has completed Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder.
It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate in Phase 2 clinical trial to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease.
Incannex Healthcare Inc. is headquartered in Sydney, Australia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 1, 24 | -0.29 Decreased by -16.01 K% | -0.72 Increased by +59.50% |
| Jun 30, 24 | -0.41 Decreased by -5.40 K% | - |
| Mar 31, 24 | -0.38 Decreased by -295.01% | - |
| Feb 26, 24 | -0.33 | - |
| Sep 30, 23 | -0.00 | - |
| Dec 31, 22 | -0.01 | - |
| Sep 30, 22 | -0.10 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 74.00 K Decreased by -92.70% | -5.42 M Decreased by -29.85% | Decreased by -7.32 K% Decreased by -1.68 K% |
| Jun 30, 24 | 12.00 K Increased by +N/A% | -6.46 M Decreased by -120.57% | Decreased by -53.84 K% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by -100.00% | -6.03 M Decreased by -68.89% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -5.24 M Decreased by -79.61% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 1.01 M Increased by +29.59% | -4.17 M Increased by +39.88% | Decreased by -411.69% Increased by +53.61% |
| Jun 30, 23 | 0.00 Decreased by N/A% | 31.41 M Increased by +935.85% | Increased by +N/A% - |
| Mar 31, 23 | 6.55 K Increased by +N/A% | -3.57 M Increased by +4.98% | Decreased by -54.56 K% - |
| Dec 31, 22 | 0.00 Decreased by -100.00% | -2.92 M Decreased by -44.32% | Decreased by N/A% Decreased by N/A% |